{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:38:44Z","timestamp":1792431524374,"version":"4.5.0"},"reference-count":68,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Carbonic Anhydrases (CAs) are ubiquitous metalloenzymes involved in several disease conditions. There are 15 human CA (hCA) isoforms and their high homology represents a challenge for the discovery of potential drugs devoid of off-target side effects. For this reason, many synthetic and pharmacologic research efforts are underway to achieve the full pharmacological potential of CA modulators of activity. We report here a novel series of sulfanilamide derivatives containing heterocyclic carboxamide moieties which were evaluated as CA inhibitors against the physiological relevant isoforms hCA I, II, IX, and XII. Some of them showed selectivity toward isoform hCA II and hCA XII. Molecular docking was performed for some of these compounds on isoforms hCA II and XII to understand the possible interaction with the active site amino acid residues, which rationalized the reported inhibitory activity.<\/jats:p>","DOI":"10.3390\/ph14080828","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T10:24:17Z","timestamp":1629714257000},"page":"828","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"first","affiliation":[{"name":"Department of Chemistry \u201cUgo Schiff\u201d, University of Florence, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy"},{"name":"Centre of Advanced Research in Bionanoconjugates and Biopolymers Department, \u201cPetru Poni\u201d Institute of Macromolecular Chemistry, 707410 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Kartsev","sequence":"additional","affiliation":[{"name":"InterBioScreen, Chernogolovka, 142432 Chernogolovka, Moscow Region, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-2710","authenticated-orcid":false,"given":"Anthi","family":"Petrou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-982X","authenticated-orcid":false,"given":"Mariana","family":"Pinteala","sequence":"additional","affiliation":[{"name":"Centre of Advanced Research in Bionanoconjugates and Biopolymers Department, \u201cPetru Poni\u201d Institute of Macromolecular Chemistry, 707410 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman M.","family":"Vydzhak","sequence":"additional","affiliation":[{"name":"Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine 1, Murmanska St, 02094 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-8476","authenticated-orcid":false,"given":"Svitlana Y.","family":"Panchishin","sequence":"additional","affiliation":[{"name":"Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine 1, Murmanska St, 02094 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodymyr","family":"Brovarets","sequence":"additional","affiliation":[{"name":"Department of Chemistry of Bioactive Nitrogen-Containing Heterocyclic Bases, V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine 1, Murmanska St, 02094 Kyiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-833X","authenticated-orcid":false,"given":"Viviana","family":"De Luca","sequence":"additional","affiliation":[{"name":"Institute of Biosciences and Bioresources, CNR, Via Pietro Castellino 111, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-2411","authenticated-orcid":false,"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[{"name":"Institute of Biosciences and Bioresources, CNR, Via Pietro Castellino 111, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-7777","authenticated-orcid":false,"given":"Athina","family":"Geronikaki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Department of Chemistry \u201cUgo Schiff\u201d, University of Florence, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature06636","article-title":"Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms","volume":"452","author":"Xu","year":"2008","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/14756366.2014.910202","article-title":"An overview of the alpha-, beta- and gamma-carbonic anhydrases from bacteria: Can bacterial carbonic anhydrases shed new light on evolution of bacteria?","volume":"30","author":"Capasso","year":"2015","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728222.2014.991312","article-title":"The eta-class carbonic anhydrases as drug targets for antimalarial agents","volume":"19","author":"Supuran","year":"2015","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3109\/14756366.2013.868599","article-title":"Biochemical characterization of the \u03b4- carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA","volume":"29","author":"Vullo","year":"2014","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/14756366.2018.1468530","article-title":"Activation of \u03b2- and \u03b3-carbonic anhydrases from pathogenic bacteria with tripeptides","volume":"33","author":"Stefanucci","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bioorg.2018.06.002","article-title":"The first activation studies of the \u03b7-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids","volume":"80","author":"Angeli","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bioorg.2018.05.027","article-title":"The zinc\u2014but not cadmium\u2014containing \u03b6-carbonic from the diatom Thalassiosira weissflogii is potently activated by amines and amino acids","volume":"80","author":"Angeli","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/156802607780636690","article-title":"Carbonic anhydrases as drug targets--an overview","volume":"7","author":"Supuran","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756366.2012.737323","article-title":"Structural annotation of human carbonic anhydrases","volume":"28","author":"Aggarwal","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/13543776.2018.1519023","article-title":"Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-94-007-7359-2_17","article-title":"Glaucoma and the applications of carbonic anhydrase inhibitors","volume":"75","author":"Scozzafava","year":"2014","journal-title":"Subcell. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Carta, F., Dumy, P., Supuran, C.T., and Winum, J.Y. (2019). Multivalent Carbonic Anhydrases Inhibitors. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215352"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.2174\/0929867325666180622120625","article-title":"State of the Art on Carbonic Anhydrase Modulators for Biomedical Purposes","volume":"26","author":"Bozdag","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/597275","article-title":"Identification of Thieno[3,2-b]Pyrrole Derivatives as Novel Small Molecule Inhibitors of Neurotropic Alphaviruses","volume":"199","author":"Peng","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/acs.jmedchem.6b01019","article-title":"Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A\/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship","volume":"60","author":"Vianello","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1021\/acs.jmedchem.7b00180","article-title":"Structural Optimizations of Thieno[3,2-b]pyrrole Derivatives for the Development of Metabolically Stable Inhibitors of Chikungunya Virus","volume":"60","author":"Ching","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/v10007-009-0016-9","article-title":"Synthesis of certain pyrrole derivatives as antimicrobial agents","volume":"59","author":"Mohamed","year":"2009","journal-title":"Acta Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/JIR.S262132","article-title":"Recent Updates on Anti-Inflammatory and Antimicrobial Effects of Furan Natural Derivatives","volume":"13","author":"Alizadeh","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_24","first-page":"345","article-title":"Synthesis and antibacterial activity studies of 2,4-di substituted furan derivatives","volume":"6","author":"Malladi","year":"2017","journal-title":"Beni Suef Univ. J. Basic Appl. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/jhet.4285","article-title":"Discovery of 4H-thieno[3,2-b]pyrrole derivatives as potential anticancer agents","volume":"58","author":"Fang","year":"2021","journal-title":"J. Heterocyclic Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104026","DOI":"10.1016\/j.bioorg.2020.104026","article-title":"Thiophene\u2013based derivatives as anticancer agents. An overview on decade\u2019s work","volume":"101","author":"Archna","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1134\/S1068162020060163","article-title":"Synthesis of New Furanone Derivatives with Potent Anticancer Activity","volume":"46","author":"Lashin","year":"2020","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bmc.2003.11.003","article-title":"Synthesis and biological evaluation of thiophene [3,2-b] pyrrole derivatives as potential anti-inflammatory agents","volume":"12","author":"Kumar","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14756366.2021.1908277","article-title":"Utility of novel 2-furanones in synthesis of other heterocyclic compounds having anti-inflammatory activity with dual COX2\/LOX inhibition","volume":"36","author":"Mahgoub","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"249780","DOI":"10.1155\/2014\/249780","article-title":"Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as anti-hyperglycemic agents","volume":"2014","author":"Mohamed","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/jm00132a003","article-title":"Thienothiopyran-2-sulfonamides: Novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma","volume":"32","author":"Baldwin","year":"1989","journal-title":"J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/1871520617666171103140749","article-title":"Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review","volume":"18","author":"Rakesh","year":"2018","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.compbiolchem.2018.04.006","article-title":"Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents","volume":"74","author":"Kachaeva","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"ref_34","first-page":"849","article-title":"Synthesis and biological evaluation of sulfonamide derivatives as antimicrobial agents","volume":"74","author":"Abbas","year":"2017","journal-title":"Acta Pol. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.1021\/acsomega.0c00280","article-title":"Design, Synthesis, and Antimicrobial Evaluation of a New Series of N-Sulfonamide 2-Pyridones as Dual Inhibitors of DHPS and DHFR Enzymes","volume":"5","author":"Azzam","year":"2020","journal-title":"ACS Omega"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hussein, E.M., Al-Rooqi, M.M., Abd El-Galil, S.M., and Ahmed, S.A. (2019). Design, synthesis, and biological evaluation of novel N4 -substituted sulfonamides: Acetamides derivatives as dihydrofolate reductase (DHFR) inhibitors. BMC Chem., 13.","DOI":"10.1186\/s13065-019-0603-x"},{"key":"ref_37","first-page":"46","article-title":"Sulfonamido Quinoxalines\u2014Search for anti-inflammatory Agents","volume":"1","author":"Ingle","year":"2012","journal-title":"IJPRAS"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1038\/s41598-019-43083-z","article-title":"Sulfenamide and Sulfonamide Derivatives of Metformin\u2014A New Option to Improve Endothelial Function and Plasma Haemostasis","volume":"9","author":"Huttunen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jscs.2015.05.007","article-title":"Synthesis and biological evaluation of pyrimidinyl sulphonamide derivatives as promising class of antitubercular agents","volume":"21","author":"Bhuva","year":"2017","journal-title":"J. Saudi Chem. Soc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1039\/C0CC04481D","article-title":"Continuous flow thermolysis of azidoacrylates for the synthesis of heterocycles and pharmaceutical intermediates","volume":"47","author":"Seeberger","year":"2011","journal-title":"Chem. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1023435605723","article-title":"Regioselective acylation of methyl 2-methyl-4H-thieno[3,2-b]pyrrole-5-carboxylate","volume":"52","author":"Yarovenko","year":"2003","journal-title":"Russ. Chem. Bull."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jhet.5570300303","article-title":"A convenient synthesis of 3,4-dihydro-2-methyl-3-oxo-2H-1,4-benzoxazine-2-carboxylic acids and 3,4-dihydro-2-methyl-3-oxo-2H-pyrido[3,2-b]-1, 4-oxazine-2-carboxylic acid","volume":"30","author":"Suhadolc","year":"1993","journal-title":"J. Heterocycl. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/BF01171157","article-title":"Synthesis of some new derivatives of dithiene-and oxathienecarboxylic acids","volume":"30","author":"Mamedov","year":"1994","journal-title":"Chem. Heterocycl. Compd."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00044-013-0757-3","article-title":"Synthesis, characterization, and anticancer studies of S and N alkyl piperazine-substituted positional isomers of 1,2,4-triazole derivatives","volume":"23","author":"Murty","year":"2014","journal-title":"Med. Chem. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1134\/S107042801406013X","article-title":"Synthesis of 12-hetaryl-9,9-dimethyl-7,8,9,10-tetrahydrobenzo[a]acridin-11(12H)-ones","volume":"50","author":"Kozlov","year":"2014","journal-title":"Russ. J. Org. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00706-007-0794-z","article-title":"Synthesis, antiinflammatory and antimicrobial activities of some 2,4-dichloro-5-fluorophenyl substituted arylidenetriazolothiazolidinones","volume":"139","author":"Karthikeyan","year":"2008","journal-title":"Monatsh. Chem."},{"key":"ref_47","first-page":"1006","article-title":"Synthesis and evaluation of anti-inflammatory activity of some thiazolo[3,2-b]-1,2,4-triazole-5(6H)-ones and their Michael addition products","volume":"49","author":"Tozkoparan","year":"1999","journal-title":"Arzneim. Forsch."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s11172-012-0299-8","article-title":"Condensation of 5-(4-methylphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione with haloacetic acids","volume":"61","author":"Rzhevskii","year":"2012","journal-title":"Russ. Chem. Bull."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1107\/S010827010400410X","article-title":"6-(2-Fluorobenzylidene)-2-[1-(2-fluoro-4-biphenyl)ethyl]thiazolo[3,2-b][1,2,4]triazol-5(6H)-one","volume":"60","author":"Koysal","year":"2004","journal-title":"Acta Crystallogr. Sect. C"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1016\/j.bmc.2005.04.058","article-title":"5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents","volume":"13","author":"Maccari","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.bmcl.2010.07.051","article-title":"Crystal structure of the C183S\/C217S mutant of human CA VII in complex with acetazolamide","volume":"20","author":"Truppo","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1021\/bi00280a011","article-title":"Nitrogen-15 nuclear magnetic resonance study of benzenesulfonamide and cyanate binding to carbonic anhydrase","volume":"22","author":"Kanamori","year":"1983","journal-title":"Biochemistry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: The rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption Using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2018.01.033","article-title":"Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"146","author":"Bonardi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11353","DOI":"10.1039\/C6OB02299E","article-title":"Intramolecular oxidative deselenization of acylselenoureas: A facile synthesis of benzoxazole amides and carbonic anhydrase inhibitors","volume":"14","author":"Angeli","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2018.05.026","article-title":"Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","volume":"154","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.8b00334","article-title":"Famotidine, an antiulcer agent, strongly inhibits helicobacter pylori and human carbonic anhydrases","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.bmc.2017.05.014","article-title":"Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Angeli","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: Automated docking with selective receptor flexiblity","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_67","unstructured":"(2021, June 08). A Structural View of Biology. Available online: http:\/\/www.rcsb.org\/."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/8\/828\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:49:49Z","timestamp":1760165389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/8\/828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ph14080828"],"URL":"https:\/\/doi.org\/10.3390\/ph14080828","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]}}}